NTCC® NA26063 LCL DNA-BioVector NTCC典型培养物保藏中心Coriell NA26063

Name：NTCC® NA26063 LCL DNA
Category分类：DNA
Cat#货号:NTCC®-Coriell NA26063
Size/Quantity数量: 1 Vial
Biosafety Level生物安全级别:1
Shipping Info运输方式: RT
Storage储存方式: 4C
Species物种来源:
Age年龄: 3 YR
Gender性别: Female
Description描述: PITT-HOPKINS SYNDROME; PTHS
Remarks: Clinically affected; onset of symptoms at 6 months; diagnosed at 2.5 years; mild dysmorphic features: slightly triangular face and small chin; microcephaly; cortical visual impairment; amblyopia (left eye); exotropia; staring spells; hypotonia; limited walking ability; constipation; global developmental delay; happy disposition; developmental milestones: first rolled over at 5 months old (but lost ability at 6 months until 12 months), could sit with support by 12 months of age; able to pull stand at 2.5 years, but not walking independent of a PT walker; unable to feed herself at 2.5 years; started to babble at 7 months old, at 2.5 years, non-verbal and with basic receptive language abilities; brain MRI and EEG at 3 years were normal; heterozygous for a de novo novel variant in the TCF4 gene: c.784_785insCA (p.Arg262ProfsX3) (human genome build GRCh37/UCSC hg19); medications/supplements: magnesium hydroxide, ergocalciferol (Vit D2), lactobacillus combo no.11, omega-3s/dha/epa/fish oil, surgeries: bilateral lateral rectus recession, left medial rectus resection, tympanostomy tubes (bilateral); assistive devices: walker; glasses; therapies: occupational, physical, and speech; family history: male maternal cousin with intermittent exotropia and delayed walking-developmentally normal at 5 years of age; female first cousin-once removed with epilepsy diagnosed in her 20s-seizures controlled with medication.
Alternate IDs其他编号:
Cell Type细胞类型: LCL
Source组织来源: LCL
Gene: TCF4
Disease疾病类型:
Mutations突变: Arg262ProfsX3 (c.784-785insCA)
Karyotypes核型:
Cytogenetics:
Mutation description突变描述:
Origin:
Transformants:
Alias别名:
Images图片:
References参考文献:

Supplier供应商:
BioVector质粒载体菌株细胞蛋白抗体基因保藏中心
NTCC典型培养物保藏中心
Tel电话：400-800-2947
Email：Biovector@163.com
http://www.biovector.net